Nitric oxide releasing solutionAlternative Names: NORS
Latest Information Update: 02 Sep 2016
At a glance
- Originator Nitric Solutions
- Class Antiacnes; Antiandrogens; Antibacterials; Antihypertensives; Antivirals; Free radicals; Nitrogen oxides; Non-opioid analgesics; Small molecules; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Tinea pedis
Most Recent Events
- 12 Aug 2016 Phase-II clinical trials in Tinea pedis in Canada (Topical) (NCT02871011)